Bitter Melon (Momordica charantia) Extract Inhibits Tumorigenicity and Overcomes Cisplatin-Resistance in Ovarian Cancer Cells Through Targeting AMPK Signaling Cascade

Objective. Acquired chemoresistance is a major obstacle in the clinical management of ovarian cancer. Therefore, searching for alternative therapeutic modalities is urgently needed. Bitter melon (Momordica charantia) is a traditional dietary fruit, but its extract also shows potential medicinal valu...

Descripción completa

Detalles Bibliográficos
Autores principales: Yung, Mingo M. H., Ross, Fiona A., Hardie, D. Grahame, Leung, Thomas H. Y., Zhan, Jinbiao, Ngan, Hextan Y. S., Chan, David W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2015
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5689379/
https://www.ncbi.nlm.nih.gov/pubmed/26487740
http://dx.doi.org/10.1177/1534735415611747

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5689379/
https://www.ncbi.nlm.nih.gov/pubmed/26487740
http://dx.doi.org/10.1177/1534735415611747

Ejemplares similares